Clinical trial
Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants (TRIDIGEP): an International Prospective Multicentric Cohort Study
NCT06267664 is registered in ClinicalTrials.gov with Hospital Clínico Universitario de Valladolid as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants (TRIDIGEP): an International Prospective Multicentric Cohort Study
- Lead sponsor
- Hospital Clínico Universitario de Valladolid
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 4, 2023
- Completion date
- December 1, 2024
- Enrollment
- 1,500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
headache disorders, migraine, migraine disorders, migraine with aura